CCM
ADPT icon

Cinctive Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Cinctive Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Buy
+53,884
New +$858K 0.05% 271
2025
Q4 		– Sell
-310,313
Closed -$4.64M – 388
2025
Q3 		$4.64M Sell
310,313
-305,431
-50% -$3.72M 0.23% 153
2025
Q2 		$7.17M Buy
615,744
+239,008
+63% +$2.17M 0.4% 88
2025
Q1 		$2.8M Buy
376,736
+135,420
+56% +$1.04M 0.22% 136
2024
Q4 		$1.45M Buy
+241,316
New +$1.33M 0.08% 258
2021
Q4 		– Sell
-43,797
Closed -$1.49M – 529
2021
Q3 		$1.49M Buy
+43,797
New +$1.58M 0.08% 343
2020
Q3 		– Sell
-43,267
Closed -$2.09M – 281
2020
Q2 		$2.09M Buy
+43,267
New +$1.58M 0.25% 179

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return